Option News Today — September 26, 2026
PerpAgent.com puts perpetual-market intelligence behind an agent interface and more — today's option signal.
Markets appear to be stabilizing after a volatile week, with the 10-year Treasury yield ending little changed. This sense of calm is also reflected in certain corners of the options market, where traders are positioning themselves in response to various signals. For instance, the options market is currently sending a contrarian signal about oil prices, suggesting that traders may be anticipating a shift in the commodity's trajectory. Meanwhile, in the stock market, traders are eyeing Meta's recent performance, with one strategist spotting a "powerful breakout" that could set up a unique trading opportunity.
Beyond the markets, there are also developments that highlight the intersection of technology, career development, and healthcare. A new agent interface from PerpAgent.com is aiming to make perpetual-market intelligence more accessible, while recent graduates and college students are being advised to think carefully about the implications of AI on their career prospects and job search strategies. On a more somber note, a promising childhood brain cancer trial has been delayed due to NIH funding cuts, with patients bearing the cost of lost time. These stories underscore the complex and multifaceted nature of today's economic and technological landscape.
Today's signal:
• PerpAgent.com puts perpetual-market intelligence behind an agent interface (PerpAgent.com)
• 10-year Treasury yield is little changed to end a volatile week (cnbc.com)
• How recent grads and college students should be thinking about AI, the CV, and the job market (cnbc.com)
• Meta's 'powerful breakout' sets up a unique trading strategy, says Mike Khouw (cnbc.com)
• The options market is sending a contrarian signal about oil prices (marketwatch.com)
• NIH funding cuts delayed a promising childhood brain cancer trial. Patients lost time they didn't have. (cnbc.com)